RxDoctor Payments Data

Debra Drescher, NP

Adult Health · Rensselaer, INNPI 1407939895

Payments from drug & device makers

$1,560in general payments, 2019–2025

Across 80 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$294
  • Bayer$283
  • AstraZeneca$202
  • Astellas Pharma US Inc$163
  • AbbVie$116
  • Novo Nordisk$102
  • plus $401 from 13 others

What the payments were for

  • Food & beverage$1,46094%
  • Education$1006%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,560 in reported general payments places this provider in the 75th percentile of 391 adult health providers in Indiana.

See all adult health providers in Indiana

Medicare billing

Part B allowed, 2024
$37,414
Medicare patients
180
Services billed
4,220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$75,086
MounjaroTirzepatide23$38,758
EliquisApixaban22$35,540
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$32,991
XareltoRivaroxaban20$28,855
JardianceEmpagliflozin15$17,241
Levothyroxine Sodium172$1,559
Rosuvastatin Calcium94$1,488
Diltiazem 24hr Er (Cd)Diltiazem Hcl25$1,434
Novolin NInsulin Nph Human Isophane13$1,381
Tamsulosin Hcl102$1,324
Albuterol Sulfate HfaAlbuterol Sulfate45$1,223
Atorvastatin Calcium174$1,187
Fentanyl12$1,123
Amlodipine Besylate178$1,071

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$102$75,08654 claims
Lilly USA, LLCMounjaro$294$38,75823 claims
PfizerEliquis$54$35,54022 claims
GSKTrelegy Ellipta$21$32,99125 claims
Boehringer IngelheimJardiance$16$17,24115 claims
AbbVieSynthroid$116$45811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 391 adult health providers in Indiana.

Other adult health in Rensselaer

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →